Who owns YS BIOPHARMA CO LTD?
- CUSIP Number: g9845f109
Tip: Access positions for across all investors
Analyze quarterly positions in Ys Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ys Biopharma stock
Who bought or sold YS BIOPHARMA CO LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 1.4M | $910k | -8% | Jun 2024 |
|
| Fil | 1.2M | $843k | 100% | Mar 2024 |
|
| FMR | 1.2M | $816k | 100% | Mar 2024 |
|
| Hillhouse Capital Advisors | 752k | $487k | 0% | Jun 2024 |
|
| Bank Of Montreal | 344k | $275k | 100% | Mar 2024 |
|
| Superstring Capital Management | 308k | $200k | 0% | Jun 2024 |
|
| Barclays | 248k | $160k | 100% | Jun 2024 |
|
| Ovata Capital Management | 150k | $10k | 100% | Jun 2024 |
|
| Citadel Advisors | 41k | $26k | 100% | Jun 2024 |
|
| Geode Capital Management | 14k | $8.8k | 0% | Jun 2024 |
|
| Susquehanna International | 12k | $7.6k | 100% | Jun 2024 |
|
Who sold out of Ys Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Pinpoint Asset Management | Mar 2024 | 50k | $3.6k |